UK markets open in 7 hours 12 minutes
NIKKEI 225
39,069.68 +282.30 (+0.73%) HANG SENG
19,636.22 +82.61 (+0.42%) CRUDE OIL
79.65 -0.15 (-0.19%) GOLD FUTURES
2,429.90 -8.60 (-0.35%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
56,149.77 +4,021.17 (+7.71%)
Kura Oncology, Inc. (KURA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.69B |
| Enterprise value | 1.18B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.34 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -2.84 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.89 |
| 52-week change 3 | 65.57% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 24.17 |
| 52-week low 3 | 7.41 |
| 50-day moving average 3 | 20.61 |
| 200-day moving average 3 | 14.61 |
Share statistics
| Avg vol (3-month) 3 | 872.71k |
| Avg vol (10-day) 3 | 642.72k |
| Shares outstanding 5 | 76.18M |
| Implied shares outstanding 6 | 76.18M |
| Float 8 | 48.62M |
| % held by insiders 1 | 1.08% |
| % held by institutions 1 | 108.87% |
| Shares short (30 Apr 2024) 4 | 10.35M |
| Short ratio (30 Apr 2024) 4 | 12.47 |
| Short % of float (30 Apr 2024) 4 | 13.72% |
| Short % of shares outstanding (30 Apr 2024) 4 | 13.58% |
| Shares short (prior month 28 Mar 2024) 4 | 10.41M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -23.43% |
| Return on equity (ttm) | -37.34% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -182.81M |
| Net income avi to common (ttm) | -168.09M |
| Diluted EPS (ttm) | -2.17 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 527.12M |
| Total cash per share (mrq) | 6.92 |
| Total debt (mrq) | 16.97M |
| Total debt/equity (mrq) | 3.36% |
| Current ratio (mrq) | 16.67 |
| Book value per share (mrq) | 6.63 |
Cash flow statement
| Operating cash flow (ttm) | -137.8M |
| Levered free cash flow (ttm) | -71.54M |
© 2024 Yahoo. All rights reserved.